0
Your cart

Your cart is empty

Books > Medicine > Clinical & internal medicine > Geriatric medicine

Buy Now

Drug Research and Development for Adults Across the Older Age Span - Proceedings of a Workshop (Paperback) Loot Price: R1,067
Discovery Miles 10 670
Drug Research and Development for Adults Across the Older Age Span - Proceedings of a Workshop (Paperback): National Academies...

Drug Research and Development for Adults Across the Older Age Span - Proceedings of a Workshop (Paperback)

National Academies of Sciences, Engineering, and Medicine, Health and Medicine Division, Board on Health Sciences Policy, Board on Health Care Services, National Cancer Policy Forum, Forum on Drug Discovery, Development, and Translation, Forum on Aging Disability and Independence; Edited by Carolyn Shore, Erin Hammers Forstag

 (sign in to rate)
Loot Price R1,067 Discovery Miles 10 670 | Repayment Terms: R100 pm x 12*

Bookmark and Share

Expected to ship within 12 - 17 working days

There is a void in evidence-based information for making informed decisions on how to optimize care for older adults, particularly those 80 years and over. Because older adults are vastly underrepresented in clinical trials, there is a dearth of information about the appropriate use of drugs in this population. Yet older adults have higher rates of comorbidities and simultaneous use of multiple medications than the general population, and are the majority users of many medications. Additionally, age-related physiological and pathological changes, particularly for adults 80 years of age and older, can lead to significant differences in the pharmacokinetics (PK)2 and pharmacodynamics (PD)3 of a given drug compared to the general population. On August 5 and 6, 2020, the National Academies of Sciences, Engineering, and Medicine hosted a workshop titled Drug Research and Development for Adults Across the Older Age Span. The workshop was designed to examine the challenges and opportunities in drug research and development for older adult populations, explore barriers that impede safety and efficacy studies in these populations, and share lessons learned for better understanding clinical pharmacology for populations over age 65. This publication summarizes the presentation and discussion of the workshop. Table of Contents Front Matter 1 Introduction 2 Inclusion of Older Adults in Clinical Trials: An Evolving Landscape 3 Overcoming Key Barriers 4 Alternative Study Approaches 5 Strategies for Engaging Older Adults in Clinical Research 6 Clinical Trials in the Era of COVID-19 and Beyond 7 Reflections and Key Takeaways Appendix A: References Appendix B: Workshop Agenda Appendix C: Speaker Biosketches

General

Imprint: National Academies Press
Country of origin: United States
Release date: 2022
Authors: National Academies of Sciences, Engineering, and Medicine • Health and Medicine Division • Board on Health Sciences Policy • Board on Health Care Services • National Cancer Policy Forum • Forum on Drug Discovery, Development, and Translation • Forum on Aging Disability and Independence
Editors: Carolyn Shore • Erin Hammers Forstag
Dimensions: 229 x 152mm (L x W)
Format: Paperback
Pages: 142
ISBN-13: 978-0-309-68568-9
Categories: Books > Medicine > Clinical & internal medicine > Geriatric medicine
LSN: 0-309-68568-0
Barcode: 9780309685689

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!

Partners